Kathleen M. Rupprecht

Statistics

Publications

Citations

2.5K

H-Index

Active since

1979

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Massachusetts Institute of Technology

Harvard University

Kathleen M. Rupprecht is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and molecular pharmacology.

Publications per year

1979–2011

Publications

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom et al. · Science · 2002 · 1.7K citations

Life Sciences, Immunology, Pharmacology +17

Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP.

Nahum Sonenberg, Kathleen M. Rupprecht, Sidney M. Hecht et al. · Proceedings of the National Academy of Sciences · 1979 · 264 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Identification and Biochemical Characterization of a Novel Nortriterpene Inhibitor of the Human Lymphocyte Voltage-Gated Potassium Channel, Kv1.3

John P. Felix, Randal M. Bugianesi, William A. Schmalhofer et al. · Biochemistry · 1999 · 96 citations

Natural Sciences, Medicinal Chemistry, Pharmacology +17

Correolide and Derivatives Are Novel Immunosuppressants Blocking the Lymphocyte Kv1.3 Potassium Channels

Gloria C. Koo, Joseph T. Blake, Kashmira Shah et al. · Cellular Immunology · 1999 · 81 citations

Medicine, Immunology, Pharmacology +14

Identification of a New Class of Inhibitors of the Voltage-Gated Potassium Channel, K<sub>v</sub>1.3, with Immunosuppressant Properties

William A. Schmalhofer, Jianming Bao, Owen B. McManus et al. · Biochemistry · 2002 · 64 citations

Medicine, Medicinal Chemistry, Pharmacology +17

1–5 of 18